GEN Exclusives

More »

GEN News Highlights

More »
Oct 23, 2006

BrainCells and Organon Collaborate on CNS Drugs

  • BrainCells and Organon will collaborate in the discovery and development of drugs for the treatment of central nervous system disorders.

    BrainCells will use its technology in the area of neurogenesis to identify neuroscience applications for compounds formerly in the Organon clinical-stage pipeline. When BrainCells determines the therapeutic utility for a drug candidate, the companies will work together to develop and reposition the drug for its new use.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?